Owners and management
CVR: 45618706
Secondary names: Efflux Pharma ApS
Not available
Resistance Oncology ApS (100%)
CVR · view owners
Nils Aage Brünner
CVR · view management
Active
Founded 15 May 2025
CVR · view overview
No headcount reported
Director registered: Nils Aage Brünner
CVR · 23/06/2025
View the full event history
Selskabet af 9. maj 2025 ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Nils Aage Brünner. The company is owned by Resistance Oncology ApS.
Selskabets formål er at forske, udvikle, producere og sælge lægemidler og lægemiddelkandidater samt relaterede teknologier.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Selskabet af 9. maj 2025 ApS is 45618706.
Selskabet af 9. maj 2025 ApS is owned by Resistance Oncology ApS.
The management of Selskabet af 9. maj 2025 ApS consists of Nils Aage Brünner.
Selskabet af 9. maj 2025 ApS was founded on 15 May 2025.
Selskabet af 9. maj 2025 ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Selskabet af 9. maj 2025 ApS is located at c/o PJM Group ApS, Amaliegade 13, 1256 København K.
Claim this page to add your logo and social links. Free to get started.
Selskabet af 9. maj 2025 ApS has published its interim report for the period May 15, 2025 to December 31, 2025.
As of June 23, 2025, Nils Aage Brünner is registered as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of June 23, 2025, Kasper Pasternak Jørgensen has stepped down as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, Kasper Pasternak Jørgensen is registered as adm. dir. of Selskabet af 9. maj 2025 ApS.
As of May 15, 2025, Resistance Oncology ApS is registered as an owner of Selskabet af 9. maj 2025 ApS with an ownership share of 100%.
Selskabet af 9. maj 2025 ApS was founded on May 15, 2025.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 44695065
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
